Sentence examples for baseline differences in disease from inspiring English sources

There were no significant baseline differences in disease activity between women who did and did not have a Po-P.

After adjustment for baseline differences in disease severity and co-morbidities, these patients experienced a higher mortality and morbidity compared to controls that did not receive corticosteroids.

These baseline differences may be explained by the baseline differences in disease severity between the groups, as there were more individuals in the ET group whose diabetes was being controlled with diet and lifestyle and subsequently had slightly better glycemic control (Table 1).

In conclusion, in this population-based cohort of middle-aged and elderly African-Americans free of coronary heart disease, adjustment for baseline differences in cardiovascular disease risk factors and LV mass greatly attenuated the strength of the association between LV pattern and all-cause mortality risk in women.

Pearson's Chi-Square Tests were used to compare baseline differences in morbidity and disease in incontinent and continent women.

The findings are more likely to reflect baseline differences in the viral load, genotype and degree of liver disease.

At baseline, no differences in disease severity, distributions of age and gender, or suspected reasons for acute renal failure were observed.

At baseline, no differences in disease activity were observed between patients who did or did not later develop ADA against the first anti-TNF drug (baseline ASDAS first anti-TNF: 3.52 ± 1.03 without ADA vs. 3.14 ± 0.95 with ADA, p = 0.399; baseline ASDAS second anti-TNF: 3.36 ± 0.94 without ADA vs. 3.09 ± 0.91 with ADA, p = 0.466).

However, a baseline difference in the prevalence of cerebrovascular disease and chronic obstructive pulmonary disease was identified (Table  1).

Also, linkage to in-hospital discharge register showed no baseline difference in prior diabetes, malignancies, chronic pulmonary diseases, and cardiovascular diseases when comparing patients treated with etanercept with those receiving infliximab.

26 Unexpected issues in the current study were differences in disease duration and baseline severity between the two treatment groups, which were due to chance.